Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.
Healy JR, Hart LS, Shazad AL, Gagliardi ME, Tsang M, Elias J, Ruden J, Farrel A, Rokita JL, Li Y, Wyce A, Barbash O, Batra V, Samanta M, Maris JM, Schnepp RW.
Healy JR, et al. Among authors: samanta m.
Pediatr Blood Cancer. 2020 Jun;67(6):e28267. doi: 10.1002/pbc.28267. Epub 2020 Apr 19.
Pediatr Blood Cancer. 2020.
PMID: 32307821
Free PMC article.